Twist Bioscience Corporation (0ME)
Munich
Real-time Data
06:00 AM
Day's Range
123.0552 wk Range
21.26Overview - 0ME - Twist Bioscience Corporation
Key Statistics
Valuation
Enterprise Value
3.00B
P/E (Trailing)
‪-93.57‬
Price / Sales (TTM)
‪8.25‬
EV / EBITDA
‪-18.72‬
Profitability
Gross Margin
‪52.75%‬
Profit Margin
‪50.72%‬
Operating Margin
‪-36.18%‬
Return on Assets
‪-12.10%‬
Return on Equity
‪-16.42%‬
Ownership
Shares Outstanding
62.67M
Price stats
50-Day Avg
‪30.59‬
200-Day Avg
‪27.91‬
Market Cap - 0ME - Twist Bioscience Corporation
Peers - 0ME - Twist Bioscience Corporation
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
- 0MEMunichTwist Bioscience Corporation3.10BMarket Cap+80.74%52-week change-91.62P/E (Trailing)‪50.72%‬Profit Margin
- 45EMunichNATERA INC (Common Stock) – ticker 45E27.42BMarket Cap+55.09%52-week change-125.99P/E (Trailing)‪-9.04%‬Profit Margin
- SAB0MunichSonic Healthcare Limited Sponsored ADR6.57BMarket Cap-4.54%52-week change17.60P/E (Trailing)‪5.59%‬Profit Margin
- SH5MunichSotera Health Company4.68BMarket Cap+15.24%52-week change33.06P/E (Trailing)‪13.44%‬Profit Margin
- 1HMMunichAdaptive Biotechnologies Corporation3.43BMarket Cap+49.16%52-week change-55.13P/E (Trailing)‪-20.72%‬Profit Margin
- BMZMunichBML Inc.734.67MMarket Cap-3.06%52-week change17.73P/E (Trailing)‪5.19%‬Profit Margin
- 7OC0MunichInsight Molecular Diagnostics Inc.90.97MMarket Cap+0.00%52-week change-1.68P/E (Trailing)‪56.67%‬Profit Margin
Profile Summary - 0ME - Twist Bioscience Corporation
About
Twist Bioscience Corporation is a synthetic biology and biotechnology company that develops and commercializes DNA-based products built on its proprietary silicon-based synthesis platform. Twist Bioscience Corporation’s core offerings include synthetic genes, DNA oligos, oligo pools, library preparation tools,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
